Become a Founder Member Now!

Commissioner Williams outlines OGB's emergency PBM contracts with LaVinity and SilverScripts

September 18, 2025 | 2025 Legislature LA, Louisiana


This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »

Commissioner Williams outlines OGB's emergency PBM contracts with LaVinity and SilverScripts
The Louisiana Legislature's Joint Legislative Committee on the Budget (JLCB) convened on September 18, 2025, to discuss critical contract extensions that will impact the state's Medicaid program and pharmacy benefits management (PBM) services.

A significant topic of discussion was the extension of a contract with Gallagher Benefits, which has been providing essential services since 2003. The contract extension, amounting to $5.5 million, is necessary to ensure compliance with federal Medicaid guidelines. The committee acknowledged Gallagher's satisfactory service, which includes audits, actuarial projections, and compliance expertise. However, concerns were raised by Senator Cloud regarding potential conflicts of interest, as Gallagher also receives compensation from PBMs while working for the state. In response, officials assured that new contract language would prohibit such dual compensation, aiming to protect the interests of state employees and retirees.

Another key agenda item was the emergency contract with Blue Cross Blue Shield of Louisiana, which manages the state's medical services. This contract extension is crucial as the state transitions to a new PBM model, allowing for improved data transfer and operational efficiency. The urgency of this contract stems from ongoing IT upgrades and the need to standardize processes for better service delivery.

The committee also discussed the selection of Lavinity LLC, a Louisiana-based PBM, for a one-year emergency contract, with an option for a second year. This decision reflects a strategic shift towards independent PBMs, aiming to enhance transparency and cost-effectiveness in drug pricing. Officials emphasized that the new contracts would ensure that all rebates from drug manufacturers would be passed through to the state, promoting accountability and potentially lowering costs for residents.

As the meeting concluded, the committee expressed optimism about the future of Louisiana's pharmacy benefits and Medicaid services, highlighting the importance of these contracts in maintaining quality healthcare for state employees and retirees. The discussions underscored a commitment to transparency and efficiency in managing state healthcare resources, which will ultimately benefit the community at large.

View full meeting

This article is based on a recent meeting—watch the full video and explore the complete transcript for deeper insights into the discussion.

View full meeting

Sponsors

Proudly supported by sponsors who keep Louisiana articles free in 2025

Scribe from Workplace AI
Scribe from Workplace AI